HomeEXPRS2 • STO
add
ExpreS2ion Biotech Holding AB
Previous close
kr 20.55
Day range
kr 18.28 - kr 20.00
Year range
kr 15.74 - kr 66.56
Market cap
50.61M SEK
Avg Volume
8.45K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 3.42M | 42.46% |
Operating expense | 13.82M | -36.49% |
Net income | -10.02M | -495.15% |
Net profit margin | -293.21 | -377.37% |
Earnings per share | — | — |
EBITDA | -11.30M | 44.21% |
Effective tax rate | 12.43% | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 48.77M | -28.85% |
Total assets | 73.48M | -21.83% |
Total liabilities | 30.93M | -20.36% |
Total equity | 42.55M | — |
Shares outstanding | 2.66M | — |
Price to book | 1.28 | — |
Return on assets | -37.91% | — |
Return on capital | -60.16% | — |
Cash Flow
Net change in cash
(SEK) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -10.02M | -495.15% |
Cash from operations | -10.78M | 14.14% |
Cash from investing | — | — |
Cash from financing | -178.00K | -150.42% |
Net change in cash | -9.23M | -210.64% |
Free cash flow | -7.57M | 4.75% |
About
Founded
2015
Website
Employees
20